Pharmacology Corner

Pharmacology education for healthcare professionals

  • Animations
  • Psychopharmacology
  • PowerPoints
  • About
Menu
  • Animations
  • Psychopharmacology
  • PowerPoints
  • About

Tag: plaque psoriasis

Efalizumab (Raptiva) for plaque psoriasis. EMEA recommends withdrawal of its marketing authorization, FDA issues public health advisory

Raptiva and progressive multifocal leukoencephalopathy : EMEA recommends withdrawal of marketing authorization and FDA recommends monitoring patients.

Pharmacology Corner

Pharmacology education for healthcare professionals

All rights reserved

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos